Glioblastoma: The Aggressive Brain Cancer

If you've ever heard the word "glioblastoma" in the news, chances are it was attached to a story that wasn't exactly uplifting. This is the kind of brain cancer that grabs headlines, not because it's rare, but because it's relentless.

Glioblastoma: What and How Common Is It Really?

So, what is glioblastoma, really? In doctor-speak, it’s a grade IV astrocytoma—a fast-growing, aggressive type of tumor that starts in the glial cells of the brain or spinal cord. These cells are the "glue" that hold our nervous system together, but when they go rogue, the results are devastating. Glioblastoma tends to infiltrate healthy brain tissue, making it nearly impossible to remove entirely with surgery. That’s why even with the best treatments—surgery, radiation, chemotherapy—the prognosis is still grim.

But let’s get down to the numbers, because the question on a lot of people’s minds is: How common is this, actually?

For all the attention glioblastoma gets, it’s not the most common brain tumor out there. According to the American Brain Tumor Association, roughly 14,000 people in the United States are diagnosed with glioblastoma each year. That’s out of about 330 million people—so it’s rare, but not vanishingly so. To put it another way, glioblastoma makes up about 15% of all primary brain tumors. Most brain tumors are less aggressive, but glioblastoma is responsible for the majority of deaths from brain cancer.

The disease doesn’t discriminate much by age, but it’s most commonly diagnosed in adults between 45 and 70. It affects men slightly more than women, and the causes are still mostly a mystery—no clear environmental triggers, no family history in most cases, just a roll of the genetic dice.

Why does this cancer get so much attention? Partly because it’s the same diagnosis that claimed the lives of Senator John McCain, Beau Biden, and countless others whose stories made headlines. But beyond that, it’s the sheer challenge it poses: glioblastoma is a reminder that, for all our progress in medicine, some diseases still defy easy answers.

So if you’ve ever wondered why this word keeps cropping up in news stories or fundraisers, now you know. Glioblastoma isn’t the most common cancer, but it’s one of the most feared, both for patients and doctors. And that’s what makes every new study, every clinical trial, and every story of survival so important.

What Makes Glioblastoma So Formidable?

When you start looking closer at glioblastoma, you quickly realize why it’s one of the most feared diagnoses in oncology. This isn’t just a “bad brain tumor”—it’s the most common malignant brain tumor in adults, accounting for over half of all primary malignant brain tumors in the U.S. (about 50.1%) according to the Glioblastoma Foundation and recent epidemiology reviews (Glioblastoma Foundation, MDPI).

How Common Is It, Really?

While the overall rate of brain and other nervous system cancers is about 6.1 per 100,000 people per year in the U.S., glioblastoma itself is less common but vastly more aggressive than other brain tumors (SEER). Each year, more than 10,000 Americans are expected to die from this disease (Glioblastoma Foundation).

Why Is Survival So Low?

The numbers are sobering: Median survival is just 12–18 months from diagnosis, even with the best available treatments (surgery, radiation, chemo, and sometimes new experimental therapies). Only about 5–7% of patients survive five years or longer (Mayo Clinic, The Brain Tumour Charity). The reasons for this grim outlook are baked into the biology of the tumor: glioblastoma grows fast, invades healthy brain tissue, and is often resistant to treatment (ScienceDirect). Even after aggressive therapy, the tumor almost always comes back.

Who Gets Glioblastoma?

Most people diagnosed are between 45 and 70, with men being slightly more at risk than women (Mayo Clinic). The only well-established risk factors are exposure to ionizing radiation (like prior radiation therapy to the head) and certain rare genetic disorders. For the vast majority of patients, though, there’s no clear cause—no lifestyle factor, diet, or environmental exposure you can point to (PMC, Moffitt Cancer Center). Scientists are now studying a mix of genetic markers and possible environmental influences, but nothing definitive has emerged yet (MDPI).

What’s on the Horizon?

Despite all this, research is moving forward. Scientists are exploring new ways to target glioblastoma using immunotherapy, personalized medicine, and even artificial intelligence to spot patterns in tumor genetics and predict response to treatment (WJGNet). Survival rates are gradually inching up, especially for those who qualify for clinical trials or have access to cutting-edge care, but the reality is that progress is slow.

So, while glioblastoma is not the most common cancer, it’s one of the most aggressive and devastating. Anyone touched by it—patient, family, or doctor—knows just how urgent the search for better treatments really is.

Credits:

• Glioblastoma Foundation
• Mayo Clinic
• SEER
• MDPI Epidemiology Review
• ScienceDirect
• Moffitt Cancer Center
• The Brain Tumour Charity
• WJGNet

More Credits:

• American Brain Tumor Association (abta.org)
• National Cancer Institute (cancer.gov)
• Mayo Clinic (mayoclinic.org)

The Best Weight Loss Injections of 2026: What Actually Works?

If you’ve heard friends or family raving about “the shot” that helps them lose weight, you’re not imagining things. Over the past few years, weight loss injections have gone from niche medical treatments to headline news, with everyone from celebrities to your next-door neighbor asking their doctor for a prescription. But with so many new options—and a lot of conflicting opinions online—how do you know which weight loss injections actually deliver results?

Let’s cut through the hype and look at the science behind today’s top injectable weight loss medications.

GLP-1 Agonists: The New Gold Standard

The most talked-about weight loss injections today belong to a class of drugs called GLP-1 agonists. These medications mimic a hormone that tells your brain you’re full, slows down how fast food leaves your stomach, and helps regulate blood sugar. The result? You feel fuller faster, eat less, and—if the clinical trials are to be believed—lose a significant amount of weight over time (Cleveland Clinic).

The big players in this category include:

• Tirzepatide (Mounjaro, Zepbound): As of 2026, tirzepatide is widely considered the most effective weight loss injection on the market. It activates both GLP-1 and GIP receptors, which seems to boost its power even more. In a major 2024 review, tirzepatide helped patients lose more weight than any other GLP-1 drug—outperforming both semaglutide and liraglutide (Drugs.com).
• Semaglutide (Wegovy, Ozempic): Still extremely popular, semaglutide is approved for both type 2 diabetes (as Ozempic) and weight loss (as Wegovy). Studies show it can help people shed 15–21% of their body weight on average, especially at higher doses (CNN).
• Liraglutide (Saxenda, Victoza): Once the gold standard, liraglutide is now a step behind newer options but remains an effective alternative for those who don’t tolerate other drugs (GoodRx).

Other GLP-1 medications, like dulaglutide (Trulicity) and exenatide (Bydureon), are approved for diabetes but may offer modest weight loss benefits (US News).

How Effective Are These Injections?

Clinical trials don’t mince words: these drugs work. In a 2024 analysis of 53 studies, tirzepatide came out on top for weight loss, followed by semaglutide, liraglutide, dulaglutide, and exenatide (Drugs.com). Most patients see significant results within a year, with some losing 20% or more of their starting body weight (CNN).

Side Effects and Downsides

GLP-1 injections aren’t magic bullets. The most common side effects are nausea, vomiting, diarrhea, and sometimes constipation. These usually improve over time. Rarely, more serious effects like pancreatitis, which can often ruin your entire life as you know it or kill you, or gallbladder disease can occur, and the drugs are not recommended for people with certain health conditions (PMC).

Another real-world downside: cost. These medications can be expensive, and insurance coverage varies widely (DDW Online). For many, out-of-pocket prices remain a barrier.

The Bottom Line

If you’re considering a weight loss injection, tirzepatide (Mounjaro or Zepbound) is currently the most effective option, followed closely by semaglutide (Wegovy or Ozempic). Both are proven to help people lose—and keep off—a meaningful amount of weight, as long as you keep up with the injections and make healthy lifestyle changes along the way. Liraglutide (Saxenda) is also a solid, if less potent, choice.

Of course, no medication is right for everyone, and the decision should always be made with your doctor based on your health history, goals, and budget.

Credits:

• CNN
• Drugs.com
• GoodRx
• US News
• DDW Online
• PMC

Do Vegetables Help Heal Your Damaged Pancreas Heal?

 

If you’ve ever gotten that “your pancreas isn’t happy” talk from your doctor, you know it’s not something you can just shrug off. The pancreas is like your body’s behind-the-scenes workhorse, quietly handling blood sugar and digestion. When it gets damaged—thanks to things like chronic pancreatitis, diabetes, or one too many boozy weekends—it’s natural to start wondering if you can eat your way back to health. Specifically: does loading up on vegetables actually help your pancreas heal, or is that just wishful thinking?

Let’s get one thing out of the way: vegetables aren’t a miracle cure. They can’t undo years of damage or replace lost pancreatic function. But there’s real science behind the idea that eating more veggies can give your pancreas a much-needed break, reduce inflammation, and even help it work a bit better.

First, what does the pancreas actually do?
It’s a small organ tucked behind your stomach, and it pulls double-duty: it makes enzymes that help you digest food, and it pumps out insulin to keep your blood sugar steady. When it’s damaged—say, by repeated inflammation (pancreatitis) or the wear-and-tear of Type 2 diabetes—two things happen. One, digestion gets rocky. Two, your body has a harder time managing sugar.

Where do vegetables come in?
A diet rich in vegetables can be a game-changer, and here’s why:

• Lower inflammation: Chronic inflammation is the enemy of a healthy pancreas. Leafy greens like spinach and kale, cruciferous veggies (broccoli, Brussels sprouts), and colorful peppers are loaded with antioxidants—substances that help your body fight off inflammation. According to research published in the World Journal of Gastroenterology, these antioxidants can help reduce oxidative stress and inflammation in the pancreas, which may slow the progression of damage (see WJG, 2021).

• Easier digestion: When your pancreas is struggling, high-fat, processed foods become a nightmare. Vegetables are naturally low in fat and high in fiber, which means they’re easier to break down. Fiber also helps regulate blood sugar levels (a big deal if pancreatic damage has led to diabetes).

• Supporting repair (to an extent): Some studies suggest that certain plant compounds—like flavonoids in onions, garlic, and leafy greens—can encourage tissue repair or at least protect the pancreas from further harm. While you won’t regrow lost cells, you can help your pancreas make the most of what’s left.

• Weight control: If you’re overweight, losing even a small amount can help your pancreas function better. Vegetables fill you up without piling on calories, making them a secret weapon in weight management.

What should you actually eat?
Focus on a variety of vegetables, especially non-starchy types. Think spinach, kale, broccoli, cauliflower, bell peppers, tomatoes, zucchini, asparagus, and carrots. Try to eat them steamed, roasted, or raw—avoid frying, which adds fat your pancreas can’t handle.

A few things to watch out for:
If your pancreatic function is severely compromised (like in chronic pancreatitis), you might need to limit raw veggies for a while, since they can be tough to digest. Always talk to your doctor or a registered dietitian for advice tailored to your situation.

The bottom line
Eating more vegetables can’t reverse pancreatic damage, but it can ease your symptoms, slow down further harm, and help your body function better overall. It’s not a magic bullet, but it’s one of the best tools you have.

Further Reading and Credits:

• World Journal of Gastroenterology, “The Role of Antioxidant Therapy in Chronic Pancreatitis” (2021)
• Harvard Health, “Pancreatitis Diet: What to Eat for Better Management”
• Cleveland Clinic, “Pancreas-Friendly Foods”

Remember: your fork isn’t a magic wand, but it’s a start.

What Does Ivermectin Actually Do To Kill Cancer?

When it comes to repurposed drugs, ivermectin is a wild card that’s gone from Nobel-winning antiparasitic to COVID-19 controversy, and now, a potential cancer therapy. So what’s hype, what’s hope, and what’s actually happening under the microscope?

The Science: What Ivermectin Does to Cancer Cells

1. Multiple Mechanisms of Action

Ivermectin’s anticancer activity is surprisingly broad. Studies have shown it can inhibit the proliferation (growth), metastasis (spread), and angiogenesis (blood vessel formation) of various cancer cells, while often sparing normal cells. Here’s where it gets interesting: ivermectin doesn’t just kill cancer cells through one trick, but acts on several pathways at once.

• Blocks Cellular Signaling: Ivermectin interferes with pathways that cancer cells use to grow and survive—mainly the WNT/β-catenin, Hedgehog, and PAK1 signaling cascades. These pathways are commonly hijacked by tumors to fuel uncontrolled cell division and resist therapy. By disrupting them, ivermectin essentially throws a wrench into the cancer cell’s internal wiring (Taylor & Francis, PMC).

• Induces Programmed Cell Death: Ivermectin pushes cancer cells toward apoptosis (programmed cell death), a process that’s often defective in tumors. It can trigger mitochondrial dysfunction—basically, it sabotages the cell’s energy factory—leading to cell death (OncoDaily).

• Overcomes Drug Resistance: One of cancer’s nastiest tricks is developing resistance to chemotherapy. Ivermectin is known to reverse multidrug resistance by inhibiting P-glycoprotein and other drug-efflux pumps, making cancer cells more sensitive to conventional treatments (Ovid).

• Targets Cancer Stem Cells: Early research suggests ivermectin can attack cancer stem-like cells, which are believed to drive recurrence and resistance in many tumors (Taylor & Francis).

• Immune Modulation: There’s evidence ivermectin can modulate the tumor microenvironment and may boost the immune system’s ability to recognize and attack cancer cells, especially when combined with immunotherapies (NIH).

2. What Cancers Are Affected?

Lab and animal studies have shown promising results in a wide range of cancers, including breast, prostate, colon, brain, leukemia, and melanoma. Some of the most robust data comes from breast and colon cancer models, as well as drug-resistant cancers (PMC, Frontiers in Pharmacology).

The Clinical Reality: Where Are We Now?

Despite the compelling lab data, there is no robust clinical evidence or FDA approval for ivermectin as a cancer treatment in humans. Most research remains in the preclinical stage—petri dishes and animal models. A few early-phase clinical trials are underway, such as a study investigating ivermectin combined with immunotherapy for triple-negative breast cancer (ClinicalTrials.gov), but results are still pending.

The National Cancer Institute and other groups are studying ivermectin’s “ability to kill cancer cells,” but no one in mainstream oncology is recommending it outside clinical trials (KFF Health News, Cancer Therapy Advisor).

Safety and Cautions

While ivermectin is generally safe at antiparasitic doses, the doses required for anticancer effects in animal studies are often much higher, and side effects can become a concern. Self-medicating or using “veterinary” ivermectin is dangerous and not supported by evidence (Drugs.com). I don't know about you but I have to ask why? WHY is it dangerous? No answer.

Where the Research Is Headed

• Combination Therapy: Researchers are particularly interested in using ivermectin alongside chemotherapy, immunotherapy, or targeted drugs, to see if it can enhance the effectiveness or overcome resistance.
• Targeting Specific Cancers: Trials are focusing on aggressive and drug-resistant cancers, where new options are desperately needed.
• Precision Dosing: Figuring out how to deliver ivermectin safely at effective concentrations for cancer remains a major challenge.

The Bottom Line

Ivermectin is not a miracle cure, but its ability to hit multiple cancer pathways at once makes it a fascinating research candidate. The excitement is real in the lab, but for patients, it’s still an experimental story—one that needs much more clinical evidence before it becomes part of routine cancer care.

Credits:

• Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin – Taylor & Francis
• The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug – PMC
• Antiparasitic Drug Ivermectin and Immunotherapy for Cancer – OncoDaily
• Ivermectin, a potential anticancer drug derived from an antiparasitic agent – Ovid
• US Cancer Institute Studying Ivermectin’s ‘Ability To Kill Cancer Cells’ – KFF Health News
• Giving ivermectin with pembrolizumab may increase the effect of pembrolizumab – ClinicalTrials.gov
• Official stance on ivermectin as cancer treatment – Drugs.com

Lung Cancer Treatments: What’s New, What Works, and What’s Next

Lung cancer isn’t just a headline—it’s real, it’s scary, and it’s more common than most people realize. But if you or someone you love is staring down a lung cancer diagnosis, here’s the good news: treatment options are better than ever, and the pace of progress is stunning. Let’s break down the latest in lung cancer treatments—what’s standard, what’s new, and how doctors decide what works best for each person.

The Basics: First Steps in Treatment

Lung cancer treatment isn't one-size-fits-all. It depends on the type of lung cancer (non-small cell or small cell), how far it’s spread, and your overall health. Here’s how doctors typically approach it:

1. Surgery

If the cancer is caught early and hasn’t spread, surgery can be a cure. Surgeons might remove a small part of the lung (wedge resection), a whole lobe (lobectomy), or sometimes an entire lung (pneumonectomy). Recovery can be tough, but for early-stage non-small cell lung cancer (NSCLC), this is often the best shot at a cure.

2. Radiation Therapy

Radiation uses high-energy beams—think X-rays or protons—to kill cancer cells. It’s a mainstay for people who can’t have surgery, or as a follow-up to surgery to mop up any stragglers. Newer techniques like stereotactic body radiotherapy (SBRT) allow doctors to target tumors with incredible precision, sparing healthy tissue.

3. Chemotherapy

Chemo is still a workhorse, especially for small cell lung cancer (SCLC) and for advanced stages of NSCLC. Chemo drugs travel through the bloodstream, attacking rapidly dividing cells (which is why hair and stomach cells take a hit too). It can be used before surgery (neoadjuvant), after surgery (adjuvant), or as the main treatment for cancers that have spread.

4. Targeted Therapy

Here’s where things get exciting. Some lung cancers have specific genetic mutations—like EGFR, ALK, or ROS1—that drive their growth. Researchers have developed drugs that target these mutations directly, often with fewer side effects than traditional chemo. If you’re diagnosed with lung cancer today, your tumor will likely be tested for these mutations.

5. Immunotherapy

A real game-changer in cancer care. Immunotherapy drugs (like pembrolizumab, nivolumab, and atezolizumab) help your immune system spot and attack cancer cells. For many people with advanced lung cancer, immunotherapy has extended life and sometimes even shrunk tumors that didn’t respond to anything else.

6. Combination Treatments

It’s common for doctors to use a mix—say, chemo plus immunotherapy, or targeted therapy plus radiation. The goal is to hit cancer from all angles, improving the chances of a lasting response.

What About Side Effects?

Every treatment comes with trade-offs. Surgery can mean a long recovery and sometimes reduced lung function. Chemo might bring fatigue, nausea, hair loss, and increased infection risk. Radiation can cause breathing problems or chest discomfort. Targeted therapies and immunotherapies have their own unique side effects—think rashes, diarrhea, or inflammation in the lungs or other organs.

But here’s the thing: side effect management has come a long way, too. Doctors now have better medications and strategies to keep patients comfortable and strong during treatment.

The Future: What’s Next in Lung Cancer Care?

The pace of discovery is staggering. Researchers are exploring:

• More precise gene-targeted therapies
• Personalized vaccines to train your immune system against your specific cancer
• CAR T-cell therapy (engineering your own immune cells to hunt down cancer)
• Better ways to predict which treatments will work for which patients

Clinical trials—studies of new drugs and combinations—are happening every day. If you’re facing lung cancer, ask about trials. You might be able to access tomorrow’s breakthrough today.

The Bottom Line

A lung cancer diagnosis is never easy, but the treatment landscape is more hopeful than ever. Your care team will tailor a plan based on your cancer’s unique fingerprint and your own needs. Don’t be afraid to ask questions, get second opinions, and look into clinical trials. The fight is real, but so is the hope.

---

Credits:

• American Cancer Society, National Cancer Institute, Mayo Clinic, Johns Hopkins Medicine, Cancer Research UK

Knowledge is power. When it comes to lung cancer, staying informed can make all the difference.

Lung Cancers: Types, Diagnosis, Treatments, Prognosis

 

Lung cancer doesn’t mess around. It’s one of the most common—and deadliest—cancers worldwide. But the story isn’t as simple as “smokers get lung cancer and that’s that.” There are different types, different risk factors, and, thanks to new treatments, a lot more hope than there used to be. If you or someone you love is facing lung cancer, here’s what you need to know, in plain English.

Types of Lung Cancer

Lung cancer isn’t just one disease. Doctors divide it into two main categories:

1. Non-Small Cell Lung Cancer (NSCLC)
This is by far the most common, making up about 80-85% of cases. It’s slower-growing and includes subtypes like:

• Adenocarcinoma: Usually found in the outer parts of the lungs; most common in non-smokers and younger people.
• Squamous cell carcinoma: Starts in the airways (bronchi) and is closely linked to smoking.
• Large cell carcinoma: Less common, but tends to grow and spread quickly.

2. Small Cell Lung Cancer (SCLC)
This one’s aggressive. It makes up about 10-15% of lung cancers and is almost always linked to heavy smoking. SCLC tends to grow fast and spread early, but it often responds well to initial treatment.

How Is Lung Cancer Diagnosed?

Most cases don’t cause symptoms until the disease is advanced. That’s why screening is so important for people at high risk (like heavy smokers). Here’s how diagnosis typically works:

• Imaging tests: A chest X-ray or CT scan is usually the first clue something’s wrong.
• Sputum cytology: Examining mucus coughed up from the lungs can sometimes spot cancer cells.
• Biopsy: This is the gold standard. A doctor takes a small piece of lung tissue (using a needle, bronchoscope, or surgery) and examines it under the microscope.
• Molecular testing: If cancer is found, labs often run genetic tests to look for mutations that might be targeted by newer drugs.

Treatments: What Are the Options?

The best treatment depends on the cancer’s type, stage, and your overall health. Here’s the modern toolkit:

Surgery

If the cancer is caught early and hasn’t spread, surgery to remove part or all of a lung can be curative—especially for NSCLC.

Radiation Therapy

High-energy rays can shrink tumors, kill cancer cells, or relieve symptoms. Sometimes it’s used before surgery, sometimes after, and often in combination with other treatments.

Chemotherapy

Chemo uses drugs to kill rapidly dividing cells. It’s often used to shrink tumors before surgery, mop up remaining cancer afterward, or treat advanced cancer that’s spread.

Targeted Therapy

Some lung cancers have specific gene mutations (like EGFR, ALK, or ROS1). Targeted drugs can home in on these mutations, often with fewer side effects than traditional chemo.

Immunotherapy

This is one of the biggest breakthroughs in recent years. These drugs help your own immune system recognize and destroy cancer cells. For some people with advanced lung cancer, immunotherapy has turned the tide.

Other Approaches

For small cell lung cancer, treatment usually starts with chemotherapy and radiation, since it tends to spread early. Surgery is rarely an option.

Prognosis: What to Expect

Here’s the hard truth: lung cancer can be tough to beat, especially if it’s found late. But survival rates are improving, especially for people diagnosed early or who qualify for targeted drugs or immunotherapy. Prognosis depends on:

• Type of lung cancer (NSCLC or SCLC)
• Stage at diagnosis (how far it’s spread)
• Overall health
• Molecular features (some mutations respond better to specific treatments)

Early detection is the best path to a good outcome. If you have a history of heavy smoking or other risk factors, screening with a low-dose CT scan can catch cancer before symptoms even start.

The Bottom Line

Lung cancer is serious, but it isn’t hopeless. Treatments are better than ever, and researchers are making progress every year. If you’re at risk, talk to your doctor about screening. If you’re facing a diagnosis, know that personalized medicine—matching treatment to the genetic makeup of your tumor—is changing the game.

---

Credits:

• American Cancer Society, National Cancer Institute, Mayo Clinic, Johns Hopkins Medicine, Cancer Research UK

Knowledge is power, and when it comes to lung cancer, understanding your options is the first step toward hope.

Cyclic Vomiting: What Causes Cyclic Vomiting?

 

Imagine waking up feeling fine, going about your day, and then—out of nowhere—you’re hit with a wave of relentless nausea and vomiting. This isn’t your average stomach bug. It’s a pattern that repeats itself, sometimes for years, leaving you exhausted, confused, and desperate for answers. This is what life can look like for people with cyclic vomiting syndrome (CVS).

What Is Cyclic Vomiting Syndrome?

Cyclic vomiting syndrome is exactly what it sounds like: repeated episodes of severe nausea and vomiting, separated by periods where you feel completely normal. Attacks can last for hours or even days, and they often come on without warning. For many, it feels like their body has its own private schedule for misery.

CVS can affect both kids and adults, though it’s often first diagnosed in children. The unpredictable nature of CVS makes it especially tough to manage—not to mention incredibly disruptive to school, work, and family life.

So, What Causes Cyclic Vomiting?

Here’s the frustrating part: doctors still don’t fully understand what causes CVS. But research is starting to connect the dots. Here’s what we know so far:

1. Migraine Connection

A striking number of people with CVS have a personal or family history of migraines. In fact, CVS is sometimes called a “migraine variant.” The theory: similar brain pathways might trigger both conditions, setting off waves of nausea and vomiting in CVS instead of (or in addition to) head pain. Some of the same treatments that work for migraines can also help with CVS.

2. Genetics

CVS tends to run in families, suggesting a genetic component. Certain gene mutations—especially those involved in energy production in cells (mitochondria)—have been linked to CVS in some studies.

3. Brain-Gut Connection

The gut and brain are in constant communication, and when that link gets disrupted, trouble follows. Stress, anxiety, and even excitement can trigger episodes for some people. This brain-gut misfire might explain why emotional or psychological triggers set off physical symptoms.

4. Triggers and Patterns

While the underlying cause may be mysterious, many people notice triggers that make an episode more likely. Common ones include:

• Emotional stress or excitement
• Certain foods (like chocolate or cheese)
• Sleep deprivation
• Infections
• Physical exhaustion
• Menstrual periods

Avoiding these triggers isn’t always possible, but tracking them can help you and your doctor spot patterns.

5. Other Theories

Some researchers have looked at hormonal imbalances, food allergies, or problems with the autonomic nervous system (which controls things like heartbeat and digestion). So far, no single explanation fits everyone.

How Is CVS Diagnosed?

There isn’t a single test or scan that says “you have CVS.” Diagnosis usually means ruling out other causes of vomiting (like infections, digestive diseases, or neurological problems) and matching your symptoms to established patterns. The hallmark: episodes of intense vomiting with full recovery in between.

Why Does It Matter?

Left untreated, CVS can lead to dehydration, missed work or school, and a lot of anxiety about when the next episode will hit. But with the right diagnosis and management—often a mix of lifestyle changes, trigger avoidance, and sometimes medications—most people can reduce the frequency and severity of their attacks.

The Bottom Line

Cyclic vomiting syndrome is still a bit of a medical mystery, but scientists are making progress. The migraine connection, genetics, and the brain-gut axis are all promising leads. If you (or your child) have unexplained, repeated vomiting episodes, don’t settle for “it’s just a stomach bug.” Talk to your doctor, keep a symptom diary, and push for answers. Relief is possible, and you’re definitely not alone.

---

Credits:

• Mayo Clinic, Johns Hopkins Medicine, Cleveland Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), American Migraine Foundation

Knowledge is power—especially when it comes to breaking the cycle.